Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript November 14, 2023
Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.00148, expectations were $-0.04.
Robert Blum: Good afternoon, everyone, and thank you for joining us for Aytu BioPharma’s Fiscal 2024 First Quarter Financial Results Conference Call for the period ended September 30, 2023. Joining us on today’s call is Aytu’s CEO, Josh Disbrow, and the company’s Chief Financial Officer, Mark Oki. At the...
